National Black Church Initiative Pushes to Increase African American Participation in Clinical Trials

<p>The National Black Church Initiative (NBCI) is working to increase the participation of African Americans and Latinos in clinical trials through a new partnership with the American Clinical Health Disparities Commission (ACHDC). The initiative, called the National Clinical Trials Strategic Plan, was active as of June 2026.</p>

<p>The NBCI represents 150,000 churches and 27.7 million members. The organization has long focused on reducing racial disparities in health, education, housing, and technology. The clinical trials effort addresses the historical underrepresentation of Black and Latino patients in medical research.</p>

<p>The plan covers 13 areas of clinical research, including cardiovascular disease, cancer, diabetes, mental health, and Alzheimer's disease. The ACHDC serves as the scientific and ethical oversight body, ensuring that all trials promoted by the NBCI comply with HIPAA guidelines and prioritize participant safety.</p>

<p>In June 2026, the NBCI and ACHDC announced support for Tier 1 research at Historically Black Colleges and Universities in collaboration with Howard University. The organizations are also inviting submissions of scientific papers for their publication, Enroll Now Magazine, with a deadline in June 2026.</p>

<p>The NBCI maintains a research recruitment registry to connect African American individuals with studies relevant to their medical conditions. The organization requires that any trial it supports must have informed consent, proper Institutional Review Board approval, and culturally competent investigators.</p>

<p>NBCI leaders say the effort is partly a response to the legacy of the Tuskegee Syphilis Study, which eroded trust in medical research among many Black Americans. The goal is to rebuild that trust while ensuring that new treatments are tested on populations that reflect the diversity of the country.</p>